Galecto raises $64m to finance EU filing for inhaled IPF drugPrivately-held biotech Galecto has raised $64m with an equity funding round to further research into treatments for drugs Share XGalecto raises $64m to finance EU filing for inhaled IPF drughttps://pharmaphorum.com/news/galecto-raises-64m-to-finance-eu-filing-for-inhaled-ipf-drug/
